November 20, 2020—The purpose of this guideline is to commission a full guideline revision of the 2011 ACCF/ AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy. This version replaces the 2011 guideline and addresses comprehensive evaluation and management of adults and children with hypertrophic cardiomyopathy. Diagnostic modalities such as electrocardiography, imaging and genetic testing, and management of patients include medical therapies, septal reduction therapies, sudden cardiac death risk assessment/prevention, and lifestyle considerations such as participation in activities/sports, occupation, and pregnancy.
HRS Endorsed
- Yes
Topic
- Clinical Topics
- Device Therapy
- Electrophysiology
- Hypertrophic Cardiomyopathy
- Pediatric
Resource Type
- Clinical Guidelines
Related Resources
Clinical Guidelines
2026 HRS/AHA/APHRS/EHRA/IDSA/LAHRS/PACES/STS Expert Consensus Statement Update on Cardiovascular Implantable Electronic Device Lead Management and Extraction
Provides updated guidance on CIED lead management and extraction, including indications, procedural safety, and team-based care.
April 23, 2026
Clinical Guidelines
2025 SCAI/HRS Clinical Practice Guidelines on Transcatheter Left Atrial Appendage Occlusion
Evidence-based guidance from SCAI and HRS on the use of transcatheter left atrial appendage occlusion for stroke prevention in atrial fibrillation, including patient selection, imaging,…
August 4, 2025
Clinical Guidelines
2024 HRS Expert Consensus Statement on Arrhythmias in the Athlete: Evaluation, Treatment, and Return to Play
Guidance on evaluating and managing arrhythmias in athletes, including risk stratification, treatment options, and return-to-play decision-making.
May 17, 2024